CanadaNov 11, 2026, 1:04 AM ETCelestica Inc. (CLS) Stock, CLS:CA StockOakoff InvestmentsInvesting GroupSummaryCelestica remains a compelling buy after a sharp correction, with no fundamental deterioration justifying the recent sell-off.CLS's CCS segment is driving robust revenue and margin growth, with hyperscaler CAPEX and new platform ramps supporting multi-year upside.Recent equity dilution funds capacity expansion, but liquidity remains strong, and further large issuances are not expected near-term.I see 98% upside potential in 12 months, assuming a 20x FY2027 EPS multiple and continued execution on growth catalysts.Looking for a helping hand in the market? Members of Beyond the Wall Investing get exclusive ideas and guidance to navigate any climate.